---
url: https://reconstrategy.com/2025/04/preclinical-licensing-deals-realized-value/
title: "Preclinical Licensing Deals Realized Value - Recon Strategy"
clipped: 2025-12-23 13:05
source: slack
slack_channel: mkt-research-headlines
---

# Preclinical Licensing Deals Realized Value - Recon Strategy

> Source: [https://reconstrategy.com/2025/04/preclinical-licensing-deals-realized-value/](https://reconstrategy.com/2025/04/preclinical-licensing-deals-realized-value/)

* [December 11, 2025](https://reconstrategy.com/2025/12/11/)

### [Winning on route of administration isn’t enough – lessons from Sotyktu](https://reconstrategy.com/2025/12/winning-on-route-of-administration-isnt-enough-lessons-from-sotyktu/)

* By 
  Jason Brauner, Phil Berk, and Lilian Zhang

* [Biopharma](https://reconstrategy.com/category/biopharma/)

Introduction
As we described in a prior whitepaper, explaining over- and under-performance of newly launched therapies relative to pre-launch expectations is a critical element to enabling robust prod…

[Read More](https://reconstrategy.com/2025/12/winning-on-route-of-administration-isnt-enough-lessons-from-sotyktu/)